June 1, 2020 / 1:59 AM / a month ago

S.Korea's Celltrion says COVID-19 drug shows 100-fold reduction in viral load

SEOUL, June 1 (Reuters) - South Korea’s Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated a 100-fold reduction in viral load of the disease in animal testing.

The pharmaceutical company said the first in-human clinical trials of the treatment are set to start in July. (Reporting by Joyce Lee; Editing by Himani Sarkar)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below